Could a common sedative reverse deadly shock?
NCT ID NCT03953677
First seen Feb 04, 2026 · Last updated May 13, 2026 · Updated 12 times
Summary
This study tested whether a sedative called dexmedetomidine could help patients with severe septic shock respond better to blood-pressure-raising medications. Septic shock is a life-threatening condition where blood pressure drops dangerously low, and some patients stop responding to standard treatments. The study aimed to see if dexmedetomidine could restore that response, potentially improving survival. It was a small pilot study involving 32 adults in intensive care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.